MedAdvisor Limited ( (AU:MDR) ) just unveiled an update.
MedAdvisor Limited reported a significant decline in its financial performance for the half-year ended 31 December 2024, with profits dropping by 79.6% to $1,402,915 and revenues decreasing by 32.3% to $57,106,600. The company did not declare any dividends during this period, reflecting the challenging market conditions and potential impacts on stakeholders.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare industry, providing digital medication management solutions. The company focuses on enhancing patient engagement and improving medication adherence through its innovative platforms.
YTD Price Performance: -22.73%
Average Trading Volume: 532,008
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$93.83M
See more insights into MDR stock on TipRanks’ Stock Analysis page.